A research scientist works inside a laboratory at the Serum Institute in India, the world’s largest vaccine manufacturer, working on vaccines against the coronavirus disease (COVID-19) in Pune. (Image used for representation: Reuters) The Pune-based company halted trials on Thursday, saying it would review the situation and wait for pharmaceutical …
Read More »AstraZeneca resumes UK Oxford coronavirus vaccine trial after hiatus caused by volunteer illness
In this illustration, taken on April 10, 2020, you see small vials labeled with a ‘COVID-19 Vaccine’ label and a medical syringe. (Image: REUTERS / Archive) AstraZeneca announced Wednesday that it had “voluntarily stopped” its trial of the vaccine developed in conjunction with Oxford University after the volunteer developed an …
Read More »Maharashtra Covid-19 count crosses 10.37 lakh, death toll rises to 29,000
A woman dressed in white protective gear is in mourning after glimpsing the body of her husband, a Covid-19 victim, at a cremation site in Guwahati on September 10, 2020 (AP Photo / Anupam Nath). A total of 13,489 patients were discharged after treatment on the day, raising the number …
Read More »Oxford and AstraZeneca to Resume Coronavirus Vaccine Trial: Why It Matters
The University of Oxford, one of the leading Covid-19 vaccine developers in the world race, resumed its trial to test the drug it is developing with pharmaceutical company AstraZeneca on Saturday. The restart to demonstrate the drug’s effectiveness comes two days after he had to stop the trial after a …
Read More »Covid Roundup: Prime Minister’s Warning Message, UK Vaccine Trials Resume and More | India News
NEW DELHI: Warning people not to let their guard down until an effective coronavirus drug is developed, Prime Minister Narendra Modi on Saturday devised a catchphrase in Hindi to emphasize his point. He said: ‘Jab tak dawai nahi, tab tak dhilai nahi’ (There is no neglect until a medicine is …
Read More »Serum Institute to Resume Trial in India After DCGI Approval
After Astrazeneca resumed testing of the Oxford University coronavirus vaccine in the UK, the Serum Institute of India said on Saturday it will restart the trial in the country once allowed by the main drug regulator. Commenting on the resumption of the trial, Adar Poonawalla, executive director of the Serum …
Read More »Astrazeneca gets regulator go-ahead to resume Oxford vaccine trial in UK
British-Swedish firm Astrazeneca said it had resumed testing of the coronavirus vaccine from the University of Oxford in the UK following confirmation from the Medicines Health Regulatory Authority (MHRA). The advanced COVID-19 vaccine trial developed by the University of Oxford and Astrazeneca was suspended this week after illness in a …
Read More »AstraZeneca trial of Oxford coronavirus vaccine resumes after UK green light
Pharmaceutical giant AstraZeneca said Saturday that it had resumed a trial of the Covid-19 vaccine after getting the go-ahead from British regulators, following a hiatus caused by a UK volunteer who fell ill. “Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have been resumed in the UK following confirmation …
Read More »DCGI Orders Serum Institute of India to Suspend Recruitment for Oxford Covid-19 Vaccine Trials | India News
NEW DELHI: The Controller General of Medicines of India (DCGI) has directed the Serum Institute of India to suspend until new hires are ordered in the phase 2 and 3 clinical trials of the Oxford Covid-19 vaccine candidate in the context of the pharmaceutical giant AstraZeneca stopping trials in other …
Read More »Covid vaccine trial stopped after volunteer showed neurological symptoms
A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that led to a pause in testing, a spokesman for the pharmaceutical AstraZeneca said on Thursday. The study participant in the late-stage trials reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, company spokesman …
Read More »